- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02434887
Clinical Study for Perceived Effectiveness Evaluation of Moisturizing Action of Intimate Use Product in Postmenopausal Women (CLIN ST EF EV)
November 9, 2015 updated by: Kley Hertz S/A
The purpose of this study is to verify the effectiveness of the investigational product through Subjective Assessment and answered by volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female aged between 45 to 65 years old
- Sexually active volunteers, with a minimum of 1 intercourse per week
- In menopause for at least 6 months;
- Intact skin in the product analysis region;
- No prior reactions to topical products
- Reading, understanding, agreement and signature of the informed consent form
Exclusion Criteria:
- Use of anti-inflammatory and immunosuppressive ( in the last 30 days and during the study)
- Active skin diseases (local or disseminated) in the evaluation área;
- Diseases that cause imune suppression;
- Endocrine disorders such as thyroid, ovarian or adrenal gland disorders;
- Any infection in the region where the product will be analyzed diagnosed at enrollment;
- Other conditions considered by the investigator physician as reasonable for the disqualification of the individual's participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of the product's efficiency as a moisturizer through subjective evaluation
Time Frame: 40 days
|
40 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
April 15, 2015
First Submitted That Met QC Criteria
April 30, 2015
First Posted (Estimate)
May 6, 2015
Study Record Updates
Last Update Posted (Estimate)
November 10, 2015
Last Update Submitted That Met QC Criteria
November 9, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- KLEY HERTZ-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Female Dry Genital Mucosa
-
Kley Hertz S/ACompleted
-
Centre Hospitalier Universitaire de NiceTerminatedVulvar Intraepithelial Neoplasia | Vulvar Mucosa LesionsFrance
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedFemale Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III StatusItaly
-
Arizona State UniversityCatholic Charities Phoenix; Phoenix International Refugee Committee; Refugee... and other collaboratorsCompletedFemale Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III StatusUnited States
-
Uppsala UniversityMalmö UniversityCompletedFemale Circumcision | Female Genital Mutilation/CuttingSweden
-
The University of Texas Medical Branch, GalvestonM.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaboratorsActive, not recruitingMalignant Neoplasms of Female Genital OrgansUnited States
-
Assiut UniversityNot yet recruitingFemale Genital Mutilation
-
Genewel Co., LtdUnknownGenital Diseases, FemaleKorea, Republic of
-
Northwestern UniversityCompletedMalignant Female Reproductive System NeoplasmUnited States
Clinical Trials on KL029 Intimate Lubricant Gel
-
Kley Hertz S/ACompleted
-
Kley Hertz S/ACompleted
-
Herbarium Laboratorio Botanico LtdaCompletedVaginal Diseases | Atrophic VaginitisBrazil
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Alcon ResearchCompletedDry EyeAustralia, Canada
-
Kley Hertz S/AUnknown
-
Alcon ResearchCompleted
-
Church & Dwight Company, Inc.CompletedCumulative IrritationUnited States